The effects of dithiaden on nitric oxide production by RAW 264.7 cells
Status PubMed-not-MEDLINE Jazyk angličtina Země Slovensko Médium print
Typ dokumentu časopisecké články
PubMed
21218118
PubMed Central
PMC2994028
DOI
10.2478/v10102-010-0044-9
Knihovny.cz E-zdroje
- Klíčová slova
- RAW 264.7 cells, dithiaden, inducible nitric oxide synthase, lipopolysaccharide, nitric oxide, nitrites,
- Publikační typ
- časopisecké články MeSH
As reported in our previous studies, dithiaden (an antagonist of histamine H(1)-receptor, used clinically as an anti-allergic or anti-emetic drug) in a concentration range of 5×10(-5)-10(-4) M decreased the production of reactive oxygen species by phagocytes. In this study we investigated the influence of dithiaden on nitric oxide (NO) production by LPS-stimulated macrophages.The cell viability in the presence of 10(-4)-5×10(-5) M dithiaden was evaluated by an ATP-test. RAW 264.7 cells (2.5×10(6)/well) were preincubated with dithiaden for 60 mins and subsequently stimulated with 0.1 µg/ml of bacterial lipopolysaccharide. After incubating for 24 hours the NO production was determined spectrophotometrically using Griess reaction as a concentration of nitrites (the end product of NO metabolism) accumulated in the cell supernatants. The expression of inducible nitric oxide synthase (iNOS) in cell-lysates was evaluated using Western blot analysis. Scavenging properties of dithiaden against NO were evaluated amperometrically.Our data demonstrate that dithiaden in the concentration of 5×10(-5) M (approved by ATP test as non toxic) caused a significant decrease in the accumulation of nitrites, and in addition, this decline was followed by a marked reduction of iNOS protein expression. Amperometrical analysis did not show any scavenging properties of dithiaden against NO.From this data it can be suggested that the inhibition effect of dithiaden on macrophage NO production is caused exclusively by the suppression of iNOS protein expression.
Zobrazit více v PubMed
Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol. 2001;60:1133–1142. PubMed
De Vos C. H1-receptor antagonists: effects on leukocytes, myth or reality? Clin Exp Allergy. 1999;29(3):60–63. PubMed
Feelisch M, Kelm M. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun. 1991;180:286–293. PubMed
Church MK. H(1)-antihistamines and inflammation. Clin Exp Allergy. 2001;31:1341–1343. PubMed
Jancinova V, Drabikova K, Nosal R, Holomanova D. Extra- and intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine. Neuro Endocrinol Lett. 2006;27(2):141–143. PubMed
Kralova J, Ciz M, Nosal R, Drabikova K, Lojek A. Effect of H(1)-antihistamines on the oxidative burst of rat phagocytes. Inflamm Res. 2006;55(1):S15–16. PubMed
Kralova J, Nosal R, Drabikova K, Jancinova V, Denev P, Moravcova A, et al. Comparative investigations of the influence of H1-antihistamines on the generation of reactive oxygen species by phagocytes. Inflamm Res. 2008;57(1):S49–50. PubMed
Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol. 2002;2:787–795. PubMed
Lullmann H, Plosch H, Ziegler A. Ca replacement by cationic amphiphilic drugs from lipid monolayers. Biochem Pharmacol. 1980;29:2969–2974. PubMed
McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med. 1996;184:1519–1524. PubMed PMC
Migliorini P, Corradin G, Corradin SB. Macrophage NO2– production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immunol Methods. 1991;139:107–114. PubMed
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012. PubMed
Nosal R, Drabikova K, Ciz M, Lojek A, Danihelova E. Effect of H1-antagonist Dithiaden on human PMN-leukocyte aggregation and chemiluminescence is stimulus-dependent. Inflamm Res. 2002;51:557–562. PubMed
Nosal R, Drabikova K, Jancinova V, Petrikova M, Fabryova V. Antiplatelet and antiphagocyte activity of H1-antihistamines. Inflamm Res. 2005;54(1):S19–20. PubMed
Nosal R, Drabikova K, Jancinova V, Macickova T, Pecivova J, Holomanova D. On the pharmacology and toxicology of neutrophils. Neuro Endocrinol Lett. 2006;27(2):148–151. PubMed
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526. PubMed
Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopoly-saccharide. Proc Natl Acad Sci U S A. 1985;82:7738–7742. PubMed PMC